Skip to main content
. 2023 Aug 10;15(8):2121. doi: 10.3390/pharmaceutics15082121

Figure 10.

Figure 10

Correlation between calix[4]arene vectors efficiency for the delivery of PNA and premiRNA. (A) Correlation for U251 glioma cell line, (B) correlation for HT29 cells. Y axis transfection efficiency for premiRNA delivery expressed as MicroRNA fold change with respect to cells treated only with the vector. X axis transfection efficiency for PNA expressed as percentage of fluorescence positive cells.